{"denoms":[{"counts":[{"groupId":"BG000","value":"377"},{"groupId":"BG001","value":"378"},{"groupId":"BG002","value":"755"}],"units":"Participants"}],"groups":[{"description":"mitoxantrone 12 mg/m\\^2 (Day 1) by intravenous (IV) every 3 weeks, and prednisone 10 mg orally given daily","id":"BG000","title":"Mitoxantrone + Prednisone"},{"description":"cabazitaxel 25 mg/m\\^2 (Day 1) by intravenous (IV) every 3 weeks, and prednisone 10 mg orally given daily","id":"BG001","title":"Cabazitaxel + Prednisone"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"47","upperLimit":"89","value":"67.0"},{"groupId":"BG001","lowerLimit":"46","upperLimit":"92","value":"68.0"},{"groupId":"BG002","lowerLimit":"46","upperLimit":"92","value":"67"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"377"},{"groupId":"BG001","value":"378"},{"groupId":"BG002","value":"755"}]}],"title":"Male"}],"paramType":"NUMBER","title":"Sex/Gender, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"106"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"203"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"11"}]}],"title":"Taiwan"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}]}],"title":"Slovakia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"19"}]}],"title":"Spain"},{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"21"}]}],"title":"Chile"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"10"}]}],"title":"Russian Federation"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"35"}]}],"title":"Italy"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"20"}]}],"title":"India"},{"categories":[{"measurements":[{"groupId":"BG000","value":"44"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"90"}]}],"title":"France"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"26"},{"groupId":"BG002","value":"45"}]}],"title":"Denmark"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"16"}]}],"title":"South Africa"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"17"}]}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"15"}]}],"title":"Korea, Republic of"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"5"}]}],"title":"Finland"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"36"}]}],"title":"Turkey"},{"categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"37"}]}],"title":"United Kingdom"},{"categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"15"}]}],"title":"Hungary"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"22"}]}],"title":"Czech Republic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"5"}]}],"title":"Mexico"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"32"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"10"}]}],"title":"Argentina"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"11"}]}],"title":"Brazil"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"31"}]}],"title":"Belgium"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"9"}]}],"title":"Singapore"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"17"}]}],"title":"Germany"},{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"21"}]}],"title":"Sweden"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"120"},{"groupId":"BG001","value":"141"},{"groupId":"BG002","value":"261"}]}],"title":"0 - Fully Active"},{"categories":[{"measurements":[{"groupId":"BG000","value":"224"},{"groupId":"BG001","value":"209"},{"groupId":"BG002","value":"433"}]}],"title":"1 - Ambulatory, Restricted Activity"},{"categories":[{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"61"}]}],"title":"2 - Ambulatory, No Work Activities"}],"paramType":"NUMBER","title":"Eastern Cooperative Oncology Group (ECOG) Performance Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"2","upperLimit":"11220","value":"127.5"},{"groupId":"BG001","lowerLimit":"2","upperLimit":"7842","value":"143.9"},{"groupId":"BG002","lowerLimit":"2","upperLimit":"11220","value":"135.00"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Prostatic Specific Antigen PSA","unitOfMeasure":"ng/mL"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"204"},{"groupId":"BG001","value":"201"},{"groupId":"BG002","value":"405"}]}],"title":"Measurable disease"},{"categories":[{"measurements":[{"groupId":"BG000","value":"173"},{"groupId":"BG001","value":"177"},{"groupId":"BG002","value":"350"}]}],"title":"Not Measurable disease"}],"description":"Measurability of the disease per Response Evaluation Criteria in Solid Tumors (RECIST) criteria:\n\nPatients with measurable disease have at least one visceral or soft tissue metastatic lesion (including new lesion).\n\nPatient with non-measurable disease have documented rising PSA levels or appearance of new lesion.","paramType":"NUMBER","title":"Measurable disease","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"356"},{"groupId":"BG001","value":"364"},{"groupId":"BG002","value":"720"}]}],"title":"Metastatic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"34"}]}],"title":"Locoregional Recurrence"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"Missing"}],"description":"Extent of the disease at screening stage:\n\n* Metastatic: bone or visceral metastases.\n* Locoregional recurrence includes local recurrent tumor at the primary site, along the draining lymphatic channels, or within the draining lymphatic nodal basin.","paramType":"NUMBER","title":"Extent of disease","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"134"},{"groupId":"BG001","value":"146"},{"groupId":"BG002","value":"280"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"117"},{"groupId":"BG001","value":"112"},{"groupId":"BG002","value":"229"}]}],"title":"2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"78"},{"groupId":"BG001","value":"73"},{"groupId":"BG002","value":"151"}]}],"title":"3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"44"},{"groupId":"BG002","value":"87"}]}],"title":"4 or more"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"8"}]}],"title":"Missing"}],"paramType":"NUMBER","title":"Tumor Location: number of sites involved","unitOfMeasure":"Participants"}]}